Quick answers
- What is Desferal?
- Desferal is a brand name of Deferoxamine mesylate, a prescription medicine. The FDA NDC Directory lists 2 Desferal products in 2 strengths and forms.
- Who makes Desferal?
- Mitem Pharma holds the FDA application for Desferal (NDA016267, approved April 1, 1968). 1 other company (repackagers or distributors) also list Desferal products.
- Is there a generic or store brand of Desferal?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Desferal product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Desferal been recalled?
- No recall linked to Desferal products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Desferal is
Each Desferal product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Deferoxamine mesylate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| deferoxamine mesylate 500 mg injection, powder, lyophilized, for solution (intramuscular, intravenous, subcutaneous) | Desferal | 2 products, 2 companies | DailyMed |
| deferoxamine mesylate 500 mg/5 mL injection, powder, for solution (intravenous, subcutaneous) | Desferal | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Deferoxamine mesylate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA016267 | Mitem Pharma | April 1, 1968 | 2 |
Companies that list Desferal
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Desferal products.
- Novartis Pharmaceuticals Corporation1 product
- Mitem Pharma1 product
Recalls
No recall linked to Desferal products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.